Advertisement
Screener

BIO-TECHNE Corp (TECH) Increase (Decrease) in Accounts Payable and Accrued Liabilities

BIO-TECHNE Corp Increase (Decrease) in Accounts Payable and Accrued Liabilities

BIO-TECHNE Corp (TECH) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $3.18 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-24

  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $6.13M.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $5.15M.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$5.99M, a 155.06% decline year-over-year.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$2.12M.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was $3.18M.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$13.95M, a 154.15% decline from fiscal 2024.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $25.77M.
  • BIO-TECHNE Corp increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$7.91M, a 162.07% decline from fiscal 2022.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2026-06-30$6.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
$11.29M
derived: sum of 2 quarters · filed 2026-08-24
$5.29M
derived: sum of 3 quarters · filed 2026-08-24
$3.18M
10-K · filed 2026-08-24
2026-03-31$5.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
-$838.00K
derived: sum of 2 quarters · filed 2026-05-06
-$2.95M
10-Q · filed 2026-05-06
-$16.27M
derived: sum of 4 quarters · filed 2026-08-24
2025-12-31-$5.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
-$8.11M
10-Q · filed 2026-02-04
-$21.42M
derived: sum of 3 quarters · filed 2026-08-24
-$22.03M
derived: sum of 4 quarters · filed 2026-08-24
2025-09-30-$2.12M
10-Q · filed 2025-11-05
-$15.43M
derived: sum of 2 quarters · filed 2026-08-24
-$16.04M
derived: sum of 3 quarters · filed 2026-08-24
-$5.16M
derived: sum of 4 quarters · filed 2026-08-24
2025-06-30-$13.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
-$13.93M
derived: sum of 2 quarters · filed 2026-08-24
-$3.04M
derived: sum of 3 quarters · filed 2026-08-24
-$13.95M
10-K · filed 2026-08-24
2025-03-31-$610.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$10.27M
derived: sum of 2 quarters · filed 2026-05-06
-$639.00K
10-Q · filed 2026-05-06
$17.97M
derived: sum of 4 quarters · filed 2026-08-24
2024-12-31$10.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
-$29.00K
10-Q · filed 2026-02-04
$18.58M
derived: sum of 3 quarters · filed 2026-08-24
$20.36M
derived: sum of 4 quarters · filed 2026-08-24
2024-09-30-$10.91M
10-Q · filed 2025-11-05
$7.70M
derived: sum of 2 quarters · filed 2026-08-24
$9.48M
derived: sum of 3 quarters · filed 2026-08-24
$17.55M
derived: sum of 4 quarters · filed 2026-08-24
2024-06-30$18.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24
$20.39M
derived: sum of 2 quarters · filed 2026-08-24
$28.46M
derived: sum of 3 quarters · filed 2026-08-24
$25.77M
10-K · filed 2026-08-24
2024-03-31$1.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08
$9.86M
derived: sum of 2 quarters · filed 2025-05-08
$7.16M
10-Q · filed 2025-05-08
$4.90M
derived: sum of 4 quarters · filed 2025-08-22
2023-12-31$8.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06
$5.38M
10-Q · filed 2025-02-06
$3.12M
derived: sum of 3 quarters · filed 2025-08-22
$9.02M
derived: sum of 4 quarters · filed 2025-08-22
2023-09-30-$2.69M
10-Q · filed 2024-11-05
-$4.96M
derived: sum of 2 quarters · filed 2025-08-22
$938.00K
derived: sum of 3 quarters · filed 2025-08-22
-$9.20M
derived: sum of 4 quarters · filed 2025-08-22
2023-06-30-$2.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22
$3.63M
derived: sum of 2 quarters · filed 2025-08-22
-$6.51M
derived: sum of 3 quarters · filed 2025-08-22
-$7.91M
10-K · filed 2025-08-22
2023-03-31$5.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06
-$4.25M
derived: sum of 2 quarters · filed 2024-05-06
-$5.65M
10-Q · filed 2024-05-06
-$4.13M
derived: sum of 4 quarters · filed 2024-08-22
2022-12-31-$10.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07
-$11.54M
10-Q · filed 2024-02-07
-$10.03M
derived: sum of 3 quarters · filed 2024-08-22
$1.38M
derived: sum of 4 quarters · filed 2024-08-22
2022-09-30-$1.40M
10-Q · filed 2023-11-07
$111.00K
derived: sum of 2 quarters · filed 2024-08-22
$11.52M
derived: sum of 3 quarters · filed 2024-08-22
$13.64M
derived: sum of 4 quarters · filed 2024-08-22
2022-06-30$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22
$12.92M
derived: sum of 2 quarters · filed 2024-08-22
$15.04M
derived: sum of 3 quarters · filed 2024-08-22
$12.74M
10-K · filed 2024-08-22
2022-03-31$11.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08
$13.53M
derived: sum of 2 quarters · filed 2023-05-08
$11.23M
10-Q · filed 2023-05-08
$18.12M
derived: sum of 4 quarters · filed 2023-08-23
2021-12-31$2.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07
-$175.00K
10-Q · filed 2023-02-07
$6.72M
derived: sum of 3 quarters · filed 2023-08-23
$10.29M
derived: sum of 4 quarters · filed 2023-08-23
2021-09-30-$2.30M
10-Q · filed 2022-11-07
$4.59M
derived: sum of 2 quarters · filed 2023-08-23
$8.16M
derived: sum of 3 quarters · filed 2023-08-23
$9.87M
derived: sum of 4 quarters · filed 2023-08-23
2021-06-30$6.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23
$10.47M
derived: sum of 2 quarters · filed 2023-08-23
$12.17M
derived: sum of 3 quarters · filed 2023-08-23
$19.09M
10-K · filed 2023-08-23
2021-03-31$3.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09
$5.28M
derived: sum of 2 quarters · filed 2022-05-09
$12.20M
10-Q · filed 2022-05-09
$12.51M
derived: sum of 4 quarters · filed 2022-08-24
2020-12-31$1.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07
$8.62M
10-Q · filed 2022-02-07
$8.94M
derived: sum of 3 quarters · filed 2022-08-24
$11.85M
derived: sum of 4 quarters · filed 2022-08-24
2020-09-30$6.92M
10-Q · filed 2021-11-08
-$6.92M
10-Q · filed 2020-11-09
$10.15M
derived: sum of 3 quarters · filed 2022-08-24
$15.80M
derived: sum of 4 quarters · filed 2022-08-24
2020-06-30$312.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24
$3.23M
derived: sum of 2 quarters · filed 2022-08-24
$8.89M
derived: sum of 3 quarters · filed 2022-08-24
$10.34M
10-K · filed 2022-08-24
2020-03-31$2.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07
$8.57M
derived: sum of 2 quarters · filed 2021-05-07
$10.03M
10-Q · filed 2021-05-07
$8.15M
derived: sum of 4 quarters · filed 2021-08-25
2019-12-31$5.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08
$7.12M
10-Q · filed 2021-02-08
$5.24M
derived: sum of 3 quarters · filed 2021-08-25
$7.83M
derived: sum of 4 quarters · filed 2021-08-25
2019-09-30$1.46M
10-Q · filed 2019-11-06
-$1.46M
10-Q · filed 2020-11-09
$2.17M
derived: sum of 3 quarters · filed 2021-08-25
$4.45M
derived: sum of 4 quarters · filed 2021-08-25
2019-06-30-$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25
$716.00K
derived: sum of 2 quarters · filed 2021-08-25
$2.99M
derived: sum of 3 quarters · filed 2021-08-25
$6.10M
10-K · filed 2021-08-25
2019-03-31$2.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11
$4.87M
derived: sum of 2 quarters · filed 2020-05-11
$7.98M
10-Q · filed 2020-05-11
$11.34M
derived: sum of 4 quarters · filed 2020-08-26
2018-12-31$2.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06
$5.38M
10-Q · filed 2020-02-06
$8.75M
derived: sum of 3 quarters · filed 2020-08-26
$15.15M
derived: sum of 4 quarters · filed 2020-08-26
2018-09-30$3.11M
10-Q · filed 2019-11-06
$6.47M
derived: sum of 2 quarters · filed 2020-08-26
$12.87M
derived: sum of 3 quarters · filed 2020-08-26
$8.70M
derived: sum of 4 quarters · filed 2020-08-26
2018-06-30$3.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26
$9.76M
derived: sum of 2 quarters · filed 2020-08-26
$5.59M
derived: sum of 3 quarters · filed 2020-08-26
$5.03M
10-K · filed 2020-08-26
2018-03-31$6.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07
$2.23M
derived: sum of 2 quarters · filed 2019-05-07
$1.67M
10-Q · filed 2019-05-07
$62.00K
derived: sum of 4 quarters · filed 2019-11-06
2017-12-31-$4.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07
-$4.74M
10-Q · filed 2019-02-07
-$6.34M
derived: sum of 3 quarters · filed 2019-11-06
-$4.29M
derived: sum of 4 quarters · filed 2019-11-06
2017-09-30-$563.00K
10-Q · filed 2018-11-07
-$2.17M
derived: sum of 2 quarters · filed 2019-11-06
-$563.00K
10-Q · filed 2017-11-09
$1.00M
derived: sum of 4 quarters · filed 2019-11-06
2017-06-30-$1.60M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06
$447.00K
derived: sum of 2 quarters · filed 2019-11-06
$1.56M
derived: sum of 3 quarters · filed 2019-11-06
$5.70M
10-K/A · filed 2019-11-06
2017-03-31$2.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09
$3.17M
derived: sum of 2 quarters · filed 2018-05-09
$7.30M
10-Q · filed 2018-05-09
$10.73M
derived: sum of 4 quarters · filed 2018-08-27
2016-12-31$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08
$5.25M
10-Q · filed 2018-02-08
$8.68M
derived: sum of 3 quarters · filed 2018-08-27
$16.24M
derived: sum of 4 quarters · filed 2018-08-27
2016-09-30$4.13M
10-Q · filed 2016-11-09
$7.57M
derived: sum of 2 quarters · filed 2018-08-27
$4.13M
10-Q · filed 2017-11-09
$13.47M
derived: sum of 4 quarters · filed 2018-08-27
2016-06-30$3.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27
$10.99M
derived: sum of 2 quarters · filed 2018-08-27
$9.34M
derived: sum of 3 quarters · filed 2018-08-27
$8.92M
10-K · filed 2018-08-27
2016-03-31$7.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10
$5.91M
derived: sum of 2 quarters · filed 2017-05-10
$5.49M
10-Q · filed 2017-05-10
$6.15M
derived: sum of 4 quarters · filed 2017-09-07
2015-12-31-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09
-$2.07M
10-Q · filed 2017-02-09
-$1.41M
derived: sum of 3 quarters · filed 2017-09-07
-$874.00K
derived: sum of 4 quarters · filed 2017-09-07
2015-09-30-$416.00K
10-Q · filed 2016-11-09
$248.00K
derived: sum of 2 quarters · filed 2017-09-07
$781.00K
derived: sum of 3 quarters · filed 2017-09-07
$3.23M
derived: sum of 4 quarters · filed 2017-09-07
2015-06-30$664.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07
$1.20M
derived: sum of 2 quarters · filed 2017-09-07
$3.64M
derived: sum of 3 quarters · filed 2017-09-07
$2.15M
10-K · filed 2017-09-07
2015-03-31$533.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10
$2.98M
derived: sum of 2 quarters · filed 2016-05-10
$1.49M
10-Q · filed 2016-05-10
$2.28M
derived: sum of 4 quarters · filed 2016-08-29
2014-12-31$2.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09
$957.00K
10-Q · filed 2016-02-09
$1.75M
derived: sum of 3 quarters · filed 2016-08-29
$3.32M
derived: sum of 4 quarters · filed 2016-08-29
2014-09-30-$1.49M
10-Q · filed 2015-11-09
-$694.00K
derived: sum of 2 quarters · filed 2016-08-29
$875.00K
derived: sum of 3 quarters · filed 2016-08-29
$709.00K
derived: sum of 4 quarters · filed 2016-08-29
2014-06-30$793.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29
$2.36M
derived: sum of 2 quarters · filed 2016-08-29
$2.20M
derived: sum of 3 quarters · filed 2016-08-29
$1.37M
10-K · filed 2016-08-29
2014-03-31$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11
$1.40M
derived: sum of 2 quarters · filed 2015-05-11
$575.00K
10-Q · filed 2015-05-11
$1.03M
derived: sum of 4 quarters · filed 2015-08-31
2013-12-31-$166.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09
-$994.00K
10-Q · filed 2015-02-09
-$536.00K
derived: sum of 3 quarters · filed 2015-08-31
-$1.01M
derived: sum of 4 quarters · filed 2015-08-31
2013-09-30-$828.00K
10-Q · filed 2014-11-10
-$370.00K
derived: sum of 2 quarters · filed 2015-08-31
-$845.00K
derived: sum of 3 quarters · filed 2015-08-31
-$803.00K
derived: sum of 4 quarters · filed 2015-08-31
2013-06-30$458.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31
-$17.00K
derived: sum of 2 quarters · filed 2015-08-31
$25.00K
derived: sum of 3 quarters · filed 2015-08-31
$243.00K
10-K · filed 2015-08-31
2013-03-31-$475.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12
-$433.00K
derived: sum of 2 quarters · filed 2014-05-12
-$215.00K
10-Q · filed 2014-05-12
-$275.00K
derived: sum of 4 quarters · filed 2014-08-29
2012-12-31$42.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04
$260.00K
10-Q · filed 2014-02-04
$200.00K
derived: sum of 3 quarters · filed 2014-08-29
$406.00K
derived: sum of 4 quarters · filed 2014-08-29
2012-09-30$218.00K
10-Q · filed 2013-11-12
$158.00K
derived: sum of 2 quarters · filed 2014-08-29
$364.00K
derived: sum of 3 quarters · filed 2014-08-29
$201.00K
derived: sum of 4 quarters · filed 2014-08-29
2012-06-30-$60.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29
$146.00K
derived: sum of 2 quarters · filed 2014-08-29
-$17.00K
derived: sum of 3 quarters · filed 2014-08-29
$1.58M
10-K · filed 2014-08-29
2012-03-31$206.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10
$43.00K
derived: sum of 2 quarters · filed 2013-05-10
$1.64M
10-Q · filed 2013-05-10
$703.00K
derived: sum of 4 quarters · filed 2013-08-29
2011-12-31-$163.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11
$1.44M
10-Q · filed 2013-02-11
$497.00K
derived: sum of 3 quarters · filed 2013-08-29
$1.69M
derived: sum of 4 quarters · filed 2013-08-29
2011-09-30$1.60M
10-Q · filed 2012-11-09
$660.00K
derived: sum of 2 quarters · filed 2013-08-29
$1.85M
derived: sum of 3 quarters · filed 2013-08-29
$1.30M
derived: sum of 4 quarters · filed 2013-08-29
2011-06-30-$938.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29
$251.00K
derived: sum of 2 quarters · filed 2013-08-29
-$296.00K
derived: sum of 3 quarters · filed 2013-08-29
-$591.00K
10-K · filed 2013-08-29
2011-03-31$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10
$642.00K
derived: sum of 2 quarters · filed 2012-05-10
$347.00K
10-Q · filed 2012-05-10
$598.00K
derived: sum of 4 quarters · filed 2012-08-29
2010-12-31-$547.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07
-$842.00K
10-Q · filed 2012-02-07
-$591.00K
derived: sum of 3 quarters · filed 2012-08-29
-$331.00K
derived: sum of 4 quarters · filed 2012-08-29
2010-09-30-$295.00K
10-Q · filed 2011-11-09
-$44.00K
derived: sum of 2 quarters · filed 2012-08-29
$216.00K
derived: sum of 3 quarters · filed 2012-08-29
-$671.00K
derived: sum of 4 quarters · filed 2012-08-29
2010-06-30$251.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29
$511.00K
derived: sum of 2 quarters · filed 2012-08-29
-$376.00K
derived: sum of 3 quarters · filed 2012-08-29
-$74.00K
10-K · filed 2012-08-29
2010-03-31$260.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-10
-$627.00K
derived: sum of 2 quarters · filed 2011-05-10
-$325.00K
10-Q · filed 2011-05-10
2009-12-31-$887.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-09
-$585.00K
10-Q · filed 2011-02-09
2009-09-30$302.00K
10-Q · filed 2010-11-09
2009-06-30$1.39M
10-K · filed 2011-08-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78